124 related articles for article (PubMed ID: 7351056)
21. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Mikulic E; Cohn JN; Franciosa JA
Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
[TBL] [Abstract][Full Text] [Related]
22. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Mehta J; Iacona M; Pepine CJ; Conti CR
Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
24. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
Amin DK; Shah PK; Hulse S; Shellock F
Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
[TBL] [Abstract][Full Text] [Related]
25. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.
Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R
Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
Beekman RH; Rocchini AP; Rosenthal A
Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade.
Fowler NO; Gabel M; Holmes JC
Circulation; 1978 Mar; 57(3):563-7. PubMed ID: 624165
[TBL] [Abstract][Full Text] [Related]
29. Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance.
Kussmaul WG; Altschuler JA; Matthai WH; Laskey WK
Circulation; 1993 Sep; 88(3):1010-5. PubMed ID: 8353862
[TBL] [Abstract][Full Text] [Related]
30. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic, ventilatory and blood gas changes during infusion of sodium nitroferricyanide (nitroprusside). Studies in patients with congestive heart failure.
Mookherjee S; Keighley JF; Warner RA; Bowser MA; Obeid AI
Chest; 1977 Sep; 72(3):273-8. PubMed ID: 891277
[TBL] [Abstract][Full Text] [Related]
32. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.
Vrobel TR; Cohn JN
Am J Cardiol; 1980 Feb; 45(2):331-6. PubMed ID: 6153497
[No Abstract] [Full Text] [Related]
33. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH
J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724
[TBL] [Abstract][Full Text] [Related]
34. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
35. Vasodilator therapy in microembolic porcine pulmonary hypertension.
McLean RF; Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1990 Jul; 71(1):35-41. PubMed ID: 2114065
[TBL] [Abstract][Full Text] [Related]
36. Combination vasodilator therapy for severe chronic congestive heart failure.
Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
[TBL] [Abstract][Full Text] [Related]
37. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
Stemple DR; Kleiman JH; Harrison DC
Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamic effects of sodium nitroprusside in 21 subjects with congestive heart failure.
Lukes SA; Romero CA; Resnekov L
Br Heart J; 1979 Feb; 41(2):187-91. PubMed ID: 426964
[TBL] [Abstract][Full Text] [Related]
39. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
Packer M; Meller J; Gorlin R; Herman MV
Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic effects of nitroprusside infusion during coronary artery operation in man.
Lappas DG; Lowenstein E; Waller J; Fahmy NR; Daggett WM
Circulation; 1976 Dec; 54(6 Suppl):III4-10. PubMed ID: 991424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
